OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Double-Edged Sword Role of Cytokines in Prostate Cancer Immunotherapy
Chenyu Mao, Yongfeng Ding, Nong Xu
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 22

Showing 22 citing articles:

Emerging Trends in Immunotherapy for Cancer
Alok Mishra, Amjad Ali, Shubham Dutta, et al.
Diseases (2022) Vol. 10, Iss. 3, pp. 60-60
Open Access | Times Cited: 46

The cytokines in tumor microenvironment: from cancer initiation-elongation-progression to metastatic outgrowth
Rajalaxmi Pradhan, Anushka Kundu, Chanakya Nath Kundu
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104311-104311
Closed Access | Times Cited: 11

Macrophage subsets and their role: co-relation with colony-stimulating factor-1 receptor and clinical relevance
Shivani Yadav, Astik Priya, Diksha R. Borade, et al.
Immunologic Research (2022) Vol. 71, Iss. 2, pp. 130-152
Open Access | Times Cited: 34

Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway
Rajalaxmi Pradhan, Subarno Paul, Biswajit Das, et al.
The Journal of Nutritional Biochemistry (2022) Vol. 113, pp. 109257-109257
Closed Access | Times Cited: 32

Emerging Immunotherapy Approaches for Treating Prostate Cancer
Lingbin Meng, Yuanquan Yang, Amir Mortazavi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14347-14347
Open Access | Times Cited: 13

Unleashing the power of peptides in prostate cancer immunotherapy: mechanism, facts and perspectives
Xiaoya Li, Fang Yang, Meijing Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

Immunotherapy in Advanced Prostate Cancer—Light at the End of the Tunnel?
Gunhild von Amsberg, Winfried Alsdorf, Panagiotis Karagiannis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2569-2569
Open Access | Times Cited: 18

Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives
Felicia Maria Maselli, Francesco Giuliani, Carmelo Laface, et al.
Current Oncology (2023) Vol. 30, Iss. 6, pp. 5769-5794
Open Access | Times Cited: 10

Prostate Cancer Vaccines: Progress, Challenges, and Future Directions
Stefanus Vicky Bernhard Elisa Runtunuwu, Trina Ekawati Tallei, Grace L. A. Turalaki
Heca Journal of Applied Sciences (2025) Vol. 3, Iss. 1, pp. 30-55
Closed Access

Reprogram to heal: Macrophage phenotypes as living therapeutics
Sheyda Ghamangiz, Abbas Jafari, Hadi Maleki, et al.
Life Sciences (2025), pp. 123601-123601
Open Access

Comparative Analysis of Cytokine Expression Profiles in Prostate Cancer Patients
Karoline Brito Caetano Andrade Coelho, Denise Kusma Wosniaki, Jônatas Luiz Pereira, et al.
Biology (2025) Vol. 14, Iss. 5, pp. 505-505
Open Access

Nanomedicines in diagnosis and treatment of prostate cancers: an updated review
Jiajia Wang, Xuan Zhang, Jiazhen Xing, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 2

Dysregulated expression of the suppressors of cytokine signaling (SOCS) contributes to the development of prostate cancer
Abdollah Jafarzadeh, Raziyeh Zandvakili, Zahra Jafarzadeh, et al.
Pathology - Research and Practice (2024) Vol. 262, pp. 155558-155558
Closed Access | Times Cited: 2

Evidence of the Link between Stroma Remodeling and Prostate Cancer Prognosis
Davide Vecchiotti, Letizia Clementi, Emanuele Cornacchia, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3215-3215
Open Access | Times Cited: 1

Oncolyic Virotherapy for Prostate Cancer: Lighting a Fire in Winter
Gongwei Wang, Ying Liu, Shuoru Liu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12647-12647
Open Access | Times Cited: 5

Modulation of inflammatory mediators underlies the antitumor effect of the combination of morusin and docetaxel on prostate cancer cells
Sana A. Fadil, Dina A. I. Albadawi, Khalid Z. Alshali, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117572-117572
Open Access

Is Minimal Change Disease Associated with Prostate Cancer or Is Age Just a Number?
Patrícia Kleinová, Matej Vnučák, Karol Graňák, et al.
Reports — Medical Cases Images and Videos (2024) Vol. 7, Iss. 3, pp. 70-70
Open Access

The Effect of Androgen Deprivation Therapy on the Cardiovascular System in Advanced Prostate Cancer
Allison B. Reiss, Samantha Vasalani, Jacqueline Albert, et al.
Medicina (2024) Vol. 60, Iss. 11, pp. 1727-1727
Open Access

Profound immunomodulatory effects of 225Ac-NM600 drive enhanced anti-tumor response in prostate cancer
Carolina A. Ferreira, Hemanth K. Potluri, Christopher Massey, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2

Higher levels of Hepatocyte Growth Factor (HGF) in human seminal plasma in comparison with blood plasma and negative association with several motile sperm cells
Larsson Anders, Carlsson Lena, Khierallah Rasha, et al.
Global Journal of Fertility and Research (2023) Vol. 8, Iss. 1, pp. 008-013
Open Access

Page 1

Scroll to top